Skip to content

Global Cord Blood Corp

CIK 0001467808

← back to feed
Revenue (TTM)
¥179.89M
−15.1% YoY FY Mar 2022
Net Income (TTM)
¥65.19M
+1.9% YoY FY Mar 2022
EPS Diluted (TTM)
¥0.54
+1.6% YoY FY Mar 2022
Gross Margin
79.6%
FY Mar 2022
Operating Margin
44.9%
FY Mar 2022
Net Margin
36.2%
FY Mar 2022
Free Cash Flow (TTM)
¥93.67M
FY Mar 2022
Cash
¥1.05B
FY Mar 2022
Total Debt
¥123.33M
FY Mar 2022
Shares Outstanding
121.55M sh
FY Mar 2022

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings